Ascites, Malignant: Clinical Trials

1 trial for Ascites, Malignant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1

Follow Ascites, Malignant: new trials by email Literature Review of Ascites, Malignant trials Research Report on Ascites, Malignant

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant Ascites
Retlirafusp Alfa + SOX + Intraperitoneal Nab-Paclitaxel - Gastric Cancer (GC), Peritoneal Metastases From Gastric Cancer
Not applicableActive not recruitingZhejiang Cancer Hospital52026-06-012026-10-02

Narrower conditions

Ascites (1)  ·  Stomach Neoplasms (1)

Broader conditions

Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Stomach Diseases (1)

Sponsors

Zhejiang Cancer Hospital (1)

Countries

China (1)

Top investigators

Jieer Ying, Dr (1)